View Cart  

Pfizer Touts Positive Results in Phase III Psoriasis Trials

Tofacitinib is part of a new class of medicines being studied in patients with moderate-to-severe plaque psoriasis, according to the drugmaker. Read More

Intuitive Surgical Gets FDA Clearance for da Vinci Sp

Actual commercialization of the system in the U.S. won’t happen until late next year, Intuitive says. Read More
The Solutions Center